Genetically Modified T Cells

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Genetically Modified T Cells, covering 2025-09-08 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma [Phase 1]